Regeneron Pharmaceuticals, Inc.

符号: REGN

NASDAQ

957

USD

今天的市场价格

26.7418
市盈率
0.3008
PEG比率
103.71B
MRK市值
0.00%
DIV收益率

Regeneron Pharmaceuticals, Inc. (REGN) 财务报表

Q: 什么是 Regeneron Pharmaceuticals, Inc. (REGN) 总资产是多少？

Regeneron Pharmaceuticals, Inc. (REGN) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Regeneron Pharmaceuticals, Inc. (REGN). 的默认数据。公司收入显示 2585.271 M 的平均值，即 0.382 % 增长率。整个期间的平均毛利润为 2297.251 M，即 0.359 %. 平均毛利率为 0.827 %. 公司去年的净收入增长率为 -0.089 %，等于 -0.111 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Regeneron Pharmaceuticals, Inc. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.132. 在流动资产领域，REGN 的报告货币为19479.2. 这些资产中的很大一部分，即 10844.8 是现金和短期投资。与去年的数据相比，该部分的变化率为-0.243%. 公司的长期投资虽然不是其重点，但以报告货币计算的5396.5（如果有的话）为5396.5。这表明与上一报告期相比，-0.183% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 2702.9. 这一数字表明，0.001% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 25973.1. 这方面的年同比变化率为 0.146%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为5667.3，存货估值为 2580.5，商誉估值为 0（如有. 无形资产总额（如果有）按 1038.6 估值.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992	1990
balance-sheet.row.cash-and-short-term-investments	40205.6	10844.8	14334.1	12532.7	6722.6	6471.1	4564.9	2896.1	1902.9	1677.4	1360.6	1083.9	587.5	526.9	626.9	341.3	474.8	766.5	459.3	298.5	296	293.8	264.3	385.1	117.6	66.2	19.8	28.9	34.5	32.7	23.6	12.5	16.4	26.2	21.8
balance-sheet.row.short-term-investments	30784.1	8114.8	4636.4	2809.1	1393.3	1596.5	1342.2	596.8	503.5	236.1	251.8	158.4	77.8	43.3	136.8	134.3	227	267.5	221.4	114	194.7	175.5	184.2	137.7	86.6	42.5	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	21595.3	5667.3	5328.7	6036.5	4114.7	2672.2	2243.2	1974.3	1611.6	1467.8	1017.4	891.8	693.1	103	93.1	65.6	35.2	18.3	7.5	36.5	43.1	15.5	4	3	13.8	0.6	5.7	6.6	4.3	2.7	1.7	1.7	1.1	1.4	0.2
balance-sheet.row.inventory	9865.6	2580.5	2401.9	1951.3	1916.6	1415.5	1151.2	726.1	399.4	238.6	128.9	70.4	28.6	13.6	-15.1	0	0	0	0	2.9	3.2	9	6.8	4	1.9	4.6	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-current-assets	1737	386.6	933	332.4	1164	959.3	243.3	225	130.5	163.5	120.7	140.8	176.2	810.5	15.1	18.6	11.5	13.1	3.2	3.4	1.6	1.9	1.8	2.2	0.8	1.6	67.4	64.1	46.2	13.8	26.7	77.6	67.2	79	0.4
balance-sheet.row.total-current-assets	73908.5	19479.2	22064.7	20520.5	12753.9	10558.8	7959.3	5596.6	3913.9	3383.8	2506.9	2252.2	1620.8	913.6	720.1	425.5	521.4	797.8	470	341.4	344	320.2	276.9	394.2	134.1	73	92.9	99.6	85	49.2	52	91.8	84.7	106.6	22.4
balance-sheet.row.property-plant-equipment-net	16300.6	4146.4	3763	3482.2	3221.6	2890.4	2575.8	2358.6	2083.4	1594.1	974.3	527	379.9	368	347.4	259.7	87.9	58.3	49.4	60.5	71.2	80.7	76.8	39.4	36.9	36.3	33	32.7	34.3	27.9	27.7	22.4	10.5	5.4	2.2
balance-sheet.row.goodwill	0	0	0	-6844.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	4067.5	1038.6	915.5	6.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0.5
balance-sheet.row.goodwill-and-intangible-assets	4067.5	1038.6	915.5	-6838	-3135.6	-3256.8	-1755	-1486.5	-864.3	-632.2	-460.2	-621.8	-463.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0.5
balance-sheet.row.long-term-investments	24562.5	5396.5	5406.4	6838	3135.6	3256.8	1755	1486.5	864.3	632.2	460.2	389.9	271.2	275.9	370.1	47.1	51.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	9795.6	2575.4	1723.7	876.9	858.9	824.2	828.7	506.3	825.3	461.9	316.1	231.9	192	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	1635.9	444.1	-4658.8	555.2	328.9	531.8	370.7	302.8	150.8	169.3	74.5	171.8	79.8	-233.8	-348.1	8.9	9.7	80.1	65.8	21.6	57.9	78.6	37.8	61.8	37.2	27.7	31	36.1	18.3	16.7	14.5	3.4	2.7	0.4	0.3
balance-sheet.row.total-non-current-assets	56362.1	13601	7149.8	4914.3	4409.4	4246.4	3775.2	3167.7	3059.5	2225.4	1364.9	698.8	459.7	410	369.4	315.7	148.6	138.4	115.1	82.1	129.2	159.3	114.6	101.2	74.1	64	64	68.8	52.6	44.6	42.2	25.8	13.2	7.4	3
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	130270.6	33080.2	29214.5	25434.8	17163.3	14805.2	11734.5	8764.3	6973.5	5609.1	3871.8	2951	2080.5	1323.6	1089.4	741.2	670	936.3	585.1	423.5	473.1	479.6	391.6	495.4	208.3	137	156.9	168.4	137.6	93.8	94.2	117.6	97.9	114	25.4
balance-sheet.row.account-payables	2361.8	606.6	589.2	564	475.5	418.1	218.2	178.2	135	141	99.5	61.9	38.9	27.7	-48	18.6	6.3	8.1	21.5	23.3	18.9	18.9	30.3	14.8	9.4	6.6	5.6	4.7	4.4	6.3	5	10.3	2.5	1.6	0
balance-sheet.row.short-term-debt	0	0	720	719.7	1631.2	0	-90.8	468.8	127.3	452.6	350.2	0.9	1.4	1	0.7	0	-162.4	202.3	-21.5	-23.3	-18.9	13.8	0.1	0.4	0.6	1.4	1.1	1.8	3.6	3.5	3.1	1.6	1	0.4	0
balance-sheet.row.tax-payables	0	0	0.3	326.3	19.5	49.4	20.8	0.2	235.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	10091	2702.9	2701.4	2699.7	2695.7	713.9	708.5	703.5	481.1	375.5	459.1	505.5	457.3	435.5	160	0	5.1	0	200	200	200	200	200	200.2	2.1	2.7	3.1	3.8	5.1	6	9.2	5.9	5.8	2.4	0
Deferred Revenue Non Current	554	126.7	69.8	515.3	635.5	1210.7	916.7	949.3	1062.4	818.2	250.3	231.2	259.2	248.6	340.6	137.9	162.4	0	123.5	69.1	56.4	68.8	5.5	6.9	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	770.4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	9571.5	2357.9	1992.2	1725.3	122.4	781.1	772.1	0.3	486.7	13.6	96.4	152.4	27.5	73.3	53.7	30.4	29.9	28.8	21.5	23.3	18.9	0	0	0	3.7	5.3	2.7	4.2	4	3.1	9.8	1.2	1.1	1.3	0
balance-sheet.row.total-non-current-liabilities	14676.8	3683.7	2701.4	3215	3331.2	1924.6	1625.2	1652.8	1543.6	1193.7	709.4	736.7	716.5	435.5	500.6	250.9	167.5	192.3	323.5	269.1	256.4	269	205.5	207	12.4	14.2	16.3	18.8	18.7	13	9.2	6.1	6.1	4.5	11.4
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	2880	720	720	719.7	717.2	713.9	708.5	703.5	481.1	364.7	312.3	185.2	160.8	160.5	160	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	28384.1	7107.1	6550.5	6666	6138	3715.5	2977.2	2620.2	2524.2	1954.3	1329.5	998.9	835.1	837.9	561.6	344.4	251.2	476	368.5	309.5	290.6	341.9	245.6	229	26.1	27.5	25.7	29.5	30.7	25.9	27.1	19.2	10.7	7.8	13.2
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.retained-earnings	106436.2	27260.3	23306.7	18968.3	10893	7379.8	5254.3	2946.7	1748.2	852.7	255.4	-92.7	-517.1	-1267.3	-1045.6	-941.1	-875.9	-793.2	-687.6	-585.3	-489.8	-531.5	-424.1	-299.7	-223.5	-200.3	-177.2	-168.6	-157	-124.6	-101.1	-70.4	-30.6	-11.4	-7
balance-sheet.row.accumulated-other-comprehensive-income-loss	-532.6	-80.9	-238.8	-26.2	29.3	21.1	-12.3	0.6	-12.8	8.6	52.3	-1.2	-1.2	-1.9	-2.5	1	-0.1	0.2	-0.2	-0.8	-3.1	-4	-3.2	-1.6	-0.8	-0.5	-26.6	-23.6	-5.9	-5.9	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	-4017.5	-1206.4	-404	-173.4	102.9	3688.7	3515.2	3196.6	2713.8	2793.5	2234.6	2045.9	1763.5	1754.8	1575.8	1336.7	1294.8	1253.2	904.4	700	675.4	673.1	573.2	567.6	406.4	310.3	335	331.1	269.8	198.4	168.2	168.8	117.8	117.6	19.2
balance-sheet.row.total-stockholders-equity	101886.5	25973.1	22664	18768.8	11025.3	11089.7	8757.3	6144.1	4449.2	3654.8	2542.3	1952.1	1245.4	485.7	527.8	396.8	418.9	460.3	216.6	114	182.5	137.6	146	266.4	182.1	109.5	131.2	138.9	106.9	67.9	67.1	98.4	87.2	106.2	12.2
balance-sheet.row.total-liabilities-and-stockholders-equity	130270.6	33080.2	29214.5	25434.8	17163.3	14805.2	11734.5	8764.3	6973.5	5609.1	3871.8	2951	2080.5	1323.6	1089.4	741.2	670	936.3	585.1	423.5	473.1	479.6	391.6	495.4	208.3	137	156.9	168.4	137.6	93.8	94.2	117.6	97.9	114	25.4
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	101886.5	25973.1	22664	18768.8	11025.3	11089.7	8757.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	130270.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	45970.9	13511.3	10042.8	9647.1	4528.9	4853.3	3097.2	2083.3	1367.7	868.3	711.9	548.3	349	319.2	506.8	181.3	278	267.5	221.4	114	194.7	175.5	184.2	137.7	86.6	42.5	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-debt	10811	2702.9	2701.4	2699.7	2695.7	713.9	708.5	703.5	481.1	375.5	459.1	505.5	457.3	435.5	160	0	5.1	202.3	200	200	200	213.8	200.2	200.6	2.7	4.1	4.2	5.6	8.7	9.5	12.3	7.5	6.8	2.8	0
balance-sheet.row.net-debt	1389.5	-27.1	-404.5	-185.9	502	-903.9	-759.2	-109.3	-54.1	-433.6	-189.7	-30.1	227.1	-48.1	47.5	-98.1	-242.7	-296.6	-37.9	15.5	98.8	95.5	120.1	-46.8	-28.3	-19.6	-15.6	-23.3	-25.8	-23.2	-11.3	-5	-9.6	-23.4	-21.8

现金流量表

在 Regeneron Pharmaceuticals, Inc. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -0.171 的转变。该公司最近通过发行 1145.5 扩大了股本，与上一年相比出现了0.000 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-3185100000.000. 与上一年相比， -0.158 发生了变化. 在同一时期，公司记录了 421, 0 和 0，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将0 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 -700.6，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992
cash-flows.row.net-income	3857.8	3953.6	4338.4	8075.3	3513.2	2115.8	2444.4	1198.5	895.5	636.1	348.1	424.4	750.3	-221.8	-104.5	-67.8	-82.7	-105.6	-102.3	-95.4	41.7	-107.5	-124.4	-76.2	-23.2	-23.1	-8.6	-11.6	-32.4	-23.5	-30.7	-39.9	-19.1	-4.5
cash-flows.row.depreciation-and-amortization	435.6	421	341.4	286.2	235.9	210.3	148.2	145.5	104.7	74.9	52.7	41.2	36.9	31.1	19.7	14.2	11.3	11.5	14.6	15.5	15.4	12.9	8.5	6.1	4.4	3.4	3	4.4	6.1	5.9	4.2	3.1	2	0.8
cash-flows.row.deferred-income-tax	-811.7	-837.8	-746.4	-147.1	75.6	-130.6	-140	318.8	-360.1	-121.6	-66.6	63.6	-340.2	0	0	-0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	876.4	885	725	601.7	432	464.3	427.4	507.3	559.9	459	307.2	198.4	94.2	56.1	39.9	31.3	32.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	105.5	-94.1	-243.3	-1916.5	-1503.6	-200.5	-697	-926.5	228.2	229.8	20.2	-190.7	-672.8	-17.5	140.9	-49.5	-52.4	87.5	93	27.8	-58.7	84.3	3.6	11	-15.3	1.2	-7.4	-2.6	-8.5	-14.8	-3	3.1	1.5	-0.6
cash-flows.row.account-receivables	-102.1	-338.8	707.8	-1927.4	-1356.1	-473.1	-268.9	-362.7	-143.8	-491.4	-62.4	-198.7	-590.1	-21.1	-27.5	-30.4	-16.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-380.7	-271.7	-696.5	-494.3	-529.4	-335.5	-387.9	-314.2	-149.8	-111.8	-60.9	-48	-52.6	0	0	-4.6	0	0	3.6	1.3	6.9	-1	-1.7	-0.9	4	-4	0	0	0	0	0	0	0	0
cash-flows.row.account-payables	478.9	598.6	-138.4	866.1	118.9	444.5	210	-23.2	254	303.7	162.2	136.7	11	0	0	13	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	109.4	-82.2	-116.2	-360.9	263	163.6	-250.2	-226.4	267.8	529.4	-18.7	-80.7	-41.1	3.7	168.5	-27.5	-35.5	87.5	89.4	26.5	-65.7	85.4	5.3	12	-19.3	5.2	-7.4	-2.6	-8.5	-14.8	0	0	0	0
cash-flows.row.other-non-cash-items	332.1	266.3	599.8	181.7	-135	-29.3	12.1	-36.9	485.7	619.8	361.6	133.7	-861.8	10.4	0.3	-0.4	2.2	34	17.9	21.9	-15.2	4.1	1.8	1.8	6.1	4.7	2.8	3.7	14.5	14.2	9	3.6	-1.6	-2.5
cash-flows.row.net-cash-provided-by-operating-activities	4738.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-764.3	-926.4	-590.1	-551.9	-614.6	-429.6	-383.1	-272.6	-511.9	-677.9	-333	-156.3	-49.3	-57.2	-99.7	-97.3	-34.9	-18.4	-2.8	-5	-6.2	-29.7	-34.4	-8.2	-6.5	-5.7	-3	-2.1	-8.6	-3.3	-6.9	-10.2	-2.1	-1
cash-flows.row.acquisitions-net	330	-54.9	-230.3	551.9	614.6	429.6	1069.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	-15554.1	-11646	-7487.9	-7048.1	-3241	-3202.4	-1845.5	-1277.1	-809.4	-557.1	-564.2	-577.3	-470.4	-240.4	-612.2	-200	-581.1	-594.4	-456.9	-103	-276.3	-287.5	-240	-191.4	-104.9	-60.1	-88	-112.6	-74.6	-28.1	-22.5	-77.3	-71.6	-137.2
cash-flows.row.sales-maturities-of-investments	11781.6	9442.2	5550.5	2215.3	3785	1604.2	775.6	544.6	274.5	327.4	476.4	378.1	439.2	426.4	276.6	297.4	646.9	527.2	306.2	223.4	277.9	253.3	215.8	124.2	53.7	83.2	93.5	75.9	38.9	38.8	61.3	68.5	82.8	61.8
cash-flows.row.other-investing-activites	-1793.9	0	-1026.8	-551.9	-614.6	-429.6	-1079.9	-732.6	-534.9	-229.7	-87.8	-199.1	-31.7	-0.3	1.1	0.1	-0.1	0	-1.6	0	0	0	0	0	0	0.1	-0.1	-0.1	0	0	0	-4.6	-0.9	-1.2
cash-flows.row.net-cash-used-for-investing-activites	-4636.5	-3185.1	-3784.6	-5384.7	-70.6	-2027.8	-1463	-1005.2	-1046.9	-907.6	-420.8	-355.5	-81.1	128.5	-434.2	0.1	30.8	-85.7	-155.1	115.5	-4.6	-63.8	-58.5	-75.4	-57.7	17.5	2.4	-38.9	-44.3	7.4	31.9	-23.6	8.2	-77.6
cash-flows.row.debt-repayment	0	0	0	0	-1500	0	0	-19.9	-40.6	-166.5	-221.7	-2	-2.2	-1.7	-1	0	-200.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-issued	1342.4	1145.5	1519.5	1672.3	2575.2	211.8	114.5	240.2	126.7	206.4	126	57.4	63.5	18.5	196.8	8.6	7.9	319.4	185	4.1	1.5	94.7	2.1	158.5	94.4	1.4	0.5	43.4	70	23.2	0	51.1	0	91.6
cash-flows.row.common-stock-repurchased	-2419.2	-2935.6	-2528.5	-2678.1	-6527.6	-463.9	-191.6	-301.7	-143.2	-160.5	-267.6	-195.1	-163.3	0	0	0	0	0	0	0	-0.9	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	0	0	0	0	0	-358.7	-500.2	-547.5	-294.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	-947.3	-700.6	-445.7	-1032.7	3481.9	-188	0	415.7	-143.2	405.3	448.6	216.9	4.3	367.4	47.5	22.8	0	0	0.4	0	3.8	13.5	-0.4	190.6	-1.5	-1.1	-1.9	-4	-3.7	-3.3	-0.2	-1.3	-0.8	-0.1
cash-flows.row.net-cash-used-provided-by-financing-activities	-1420.5	-1790.1	-1009	-1005.8	-1970.5	-252.1	-77.1	-24.4	-700.4	-262.8	-209.3	77.1	-97.6	384.2	243.3	31.4	-192.9	319.4	185.4	4.1	4.4	108.2	1.7	349.1	92.9	0.3	-1.4	39.4	66.3	19.9	-0.2	49.8	-0.8	91.5
cash-flows.row.effect-of-forex-changes-on-cash	3764.4	-0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.1	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-1319	-381.6	221.3	690.8	577	150.1	655	277.5	-273.9	160.4	113.1	305.3	-253.3	371	-94.5	-40.7	-251.1	261	53.4	89.3	-17.1	38.2	-167.3	216.4	7.3	3.9	-9.2	-5.6	1.7	9.1	11.2	-3.9	-9.8	7.1
cash-flows.row.cash-at-end-of-period	9449.7	2737.8	3119.4	2898.1	2207.3	1630.3	1480.2	812.7	535.2	809.1	648.7	535.6	230.3	483.6	112.6	207.1	247.8	498.9	237.9	184.5	101.2	118.3	80.1	247.4	31	23.7	19.7	28.9	34.4	32.7	23.7	12.5	16.4	26.3
cash-flows.row.cash-at-beginning-of-period	10768.7	3119.4	2898.1	2207.3	1630.3	1480.2	825.2	535.2	809.1	648.7	535.6	230.3	483.6	112.6	207.1	247.8	498.9	237.9	184.5	95.2	118.3	80.1	247.4	31	23.7	19.8	28.9	34.5	32.7	23.6	12.5	16.4	26.2	19.2
cash-flows.row.operating-cash-flow	4738.9	4594	5014.9	7081.3	2618.1	2430	2195.1	1307.1	1485.9	1330.8	752.4	588.6	-74.6	-141.7	96.3	-72.2	-89.1	27.4	23.1	-30.3	-16.9	-6.1	-110.5	-57.3	-27.9	-13.8	-10.2	-6.1	-20.3	-18.2	-20.5	-30.1	-17.2	-6.8
cash-flows.row.capital-expenditure	-764.3	-926.4	-590.1	-551.9	-614.6	-429.6	-383.1	-272.6	-511.9	-677.9	-333	-156.3	-49.3	-57.2	-99.7	-97.3	-34.9	-18.4	-2.8	-5	-6.2	-29.7	-34.4	-8.2	-6.5	-5.7	-3	-2.1	-8.6	-3.3	-6.9	-10.2	-2.1	-1
cash-flows.row.free-cash-flow	3974.6	3667.6	4424.8	6529.4	2003.5	2000.4	1812	1034.5	974	652.8	419.4	432.3	-124	-198.9	-3.3	-169.5	-123.9	8.9	20.3	-35.3	-23.1	-35.8	-144.9	-65.5	-34.4	-19.5	-13.2	-8.2	-28.9	-21.5	-27.4	-40.3	-19.3	-7.8

利润表行

Regeneron Pharmaceuticals, Inc. 的收入与上期相比变化了 0.078%。据报告, REGN 的毛利润为 11301.4。该公司的营业费用为 7068.2，与上年相比变化了 25.802%. 折旧和摊销费用为 421，与上一会计期间相比变化了 -0.031%. 营业费用报告为 7068.2，显示25.802% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长-0.146%. 营业收入为 4047.1，与上年相比变化了-0.146%. 净利润的变化率为 -0.089%。去年的净收入为3953.6.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992	1990
income-statement-row.row.total-revenue	13100.1	13117.2	12172.9	16071.7	8497.1	7863.4	6710.8	5872.2	4860.4	4103.7	2819.6	2104.7	1378.5	445.8	459.1	379.3	238.5	125	63.4	66.2	174	57.5	22	22	59.3	34.5	38.2	33.1	24.1	27.4	23.2	10.6	11.5	7.3	5
income-statement-row.row.cost-of-revenue	1681.7	1815.8	1560.4	2437.5	1119.9	782.2	434.1	397.1	299.7	392.7	205	155.4	84.5	4.2	2.1	1.7	0.9	0	8.1	9.6	15.2	6.7	6.5	6.5	15.6	3.6	5	2.6	1.1	0	0	0	0	12.8	6.3
income-statement-row.row.gross-profit	11418.4	11301.4	10612.5	13634.2	7377.2	7081.2	6276.7	5475.2	4560.7	3711	2614.5	1949.4	1294	441.6	457	377.6	237.5	125	55.3	56.6	158.8	50.8	15.5	15.5	43.7	30.9	33.2	30.5	23	27.4	23.2	10.6	11.5	-5.5	-1.3
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	4472.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	53.3	-20	-89.9	-45.6	-280.4	219.3	19.1	-1.1	-0.9	0	0	0	0	0	0	0	0	0	0	-248.8	0	0	0	0	4.4	3.4	3	4.4	6.1	5.9	4.2	3.1	2	0.8	0.3
income-statement-row.row.operating-expenses	7205.5	7068.2	5618.5	4687.4	3800.6	4871.4	3742.3	3395.6	3230	2459.1	1776.1	1189.4	836.3	646.8	554.5	451.7	327.4	239.5	163	-67.8	153.2	150.8	137.5	101.1	69	54.7	45.8	38	40.3	35	52.4	49.4	29.8	4.1	2
income-statement-row.row.cost-and-expenses	8887.2	8884	7178.9	7124.9	4920.5	5653.6	4176.4	3792.6	3529.7	2851.8	1981.1	1344.7	920.8	651	556.5	453.4	328.3	239.5	171.1	-58.2	168.4	157.5	143.9	107.7	84.6	58.3	50.8	40.6	41.4	35	52.4	49.4	29.8	16.9	8.3
income-statement-row.row.interest-income	562.2	495.9	160.1	45.8	18.5	30.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	35.5	73	59.4	57.3	56.9	30.2	28.2	25.1	7.2	14.2	37.4	46.4	45.3	21.3	9.1	2.3	7.8	-20.9	-16.5	-41	-48.2	-4.5	-9.4	-12.2	4.6	-1	-4.4	3.4	14.3	14.7	0	0	0	-5.2	0
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	41.6	-456.8	119.9	379	233.8	219.3	19.1	-1.1	-0.9	-12.6	-25.3	-0.2	2	3.5	2.1	4.5	17.2	20.9	16.5	41	48.2	4.5	9.4	12.2	-4.6	1	4.4	-3.4	-14.3	-14.7	0	0	0	5.2	0
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	53.3	-20	-89.9	-45.6	-280.4	219.3	19.1	-1.1	-0.9	0	0	0	0	0	0	0	0	0	0	-248.8	0	0	0	0	4.4	3.4	3	4.4	6.1	5.9	4.2	3.1	2	0.8	0.3
income-statement-row.row.total-operating-expenses	41.6	-456.8	119.9	379	233.8	219.3	19.1	-1.1	-0.9	-12.6	-25.3	-0.2	2	3.5	2.1	4.5	17.2	20.9	16.5	41	48.2	4.5	9.4	12.2	-4.6	1	4.4	-3.4	-14.3	-14.7	0	0	0	5.2	0
income-statement-row.row.interest-expense	35.5	73	59.4	57.3	56.9	30.2	28.2	25.1	7.2	14.2	37.4	46.4	45.3	21.3	9.1	2.3	7.8	-20.9	-16.5	-41	-48.2	-4.5	-9.4	-12.2	4.6	-1	-4.4	3.4	14.3	14.7	0	0	0	-5.2	0
income-statement-row.row.depreciation-and-amortization	435.6	421	434.4	436.3	290.7	210.3	148.2	145.5	104.7	74.9	52.7	41.2	36.9	31.1	19.7	14.2	11.3	11.5	14.6	15.5	15.4	12.9	8.5	6.1	4.4	3.4	3	4.4	6.1	5.9	4.2	3.1	2	0.8	0.3
income-statement-row.row.ebitda-caps	4452.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	3858.9	4047.1	4738.9	8946.8	3576.6	2209.8	2534.4	2079.6	1330.7	1251.9	838.4	760	457.7	-205.2	-97.5	-74.1	-89.8	-114.5	-107.7	124.4	5.6	-100	-122	-85.7	-25.3	-23.8	-12.6	-7.5	-17.3	-7.6	-29.2	-38.8	-18.3	-9.6	-3.3
income-statement-row.row.income-before-tax	4042	4199.3	4858.8	9325.8	3810.4	2429.1	2553.5	2078.5	1329.8	1225.1	775.7	713.4	414.4	-222.9	-104.5	-72	-80.4	-93.6	-91.1	124.4	53.9	-95.5	-112.5	-73.5	-29.9	-22.8	-8.2	-7.5	-17.3	-7.6	0	0	0	-4.4	0
income-statement-row.row.income-tax-expense	184.2	245.7	520.4	1250.5	297.2	313.3	109.1	880	434.3	589	427.7	289	-335.8	-1.1	-2.1	-4.1	2.4	-29.8	-21.9	178.8	-84.3	3	-7	-21.7	2.5	-1.7	-8.4	7.5	29.4	30.6	1.5	1.1	0.8	-10.3	0
income-statement-row.row.net-income	3857.8	3953.6	4338.4	8075.3	3513.2	2115.8	2444.4	1198.5	895.5	636.1	348.1	424.4	750.3	-221.8	-104.5	-67.8	-82.7	-105.6	-102.3	-95.4	41.7	-107.5	-124.4	-76.2	-23.2	-23.1	-8.6	-11.6	-32.4	-23.5	-30.7	-39.9	-19.1	-4.5	-3.3